Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Àíåñòåçèîëîãèÿ è ìåäèöèíà êðèòè÷åñêèõ ñîñòîÿíèé > Èíòåíñèâíàÿ òåðàïèÿ âçðîñëûõ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 17.07.2011, 14:14
Àâàòàð äëÿ AMBU
AMBU AMBU âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 14.12.2008
Ãîðîä: Àëìàòû
Ñîîáùåíèé: 32
Ñêàçàë(à) ñïàñèáî: 10
AMBU ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Îñòðàÿ ïî÷å÷íàÿ íåäîñòàòî÷íîñòü

Ïðîøó ðàçðåøèòü ìîé ñïîð ñ êîëëåãàìè.
Ïàöèåíòêà 73 ëåò, ïîñòóïàåò â ÎÐÈÒ Êàðäèîöåíòðà ñ äèàãíîçîì: ÈÁÑ. Ïåðâè÷íûé öèðêóëÿðíûé èíôàðêò ìèîêàðäà. Ñàõàðíûé äèàáåò 2 òèïà, äåêîìïåíñàöèÿ. Äèàáåòè÷åñêàÿ àíãèîïàòèÿ. Òðîìáîëèçèñ Àêòèëèçå 50 ìã íà äîãîñïèòàëüíîì ýòàïå. Ó íàñ - ñòåíòèðîâàíèå ÏÌÆÂ, ÏÊÀ (3 ñòåíòà)
Ëàáîðàòîðíî êðåàòèíèí 188, ìî÷åâèíà 16 ïðè ïîñòóïëåíèè.
Ñ ïîëîæèòåëüíîé äèíàìèêîé ïåðåâîäèòñÿ â ê/î íà ñëåäóþùèé äåíü.
×åðåç äâîå ñóòîê âûçîâ ðåàíèìàòîëîãà ïî ïîâîäó àíóðèè è íàðàñòàíèÿ êðåàòèíèíà äî 400 ìêìîëü/ë, ìî÷åâèíû äî 30 ììîëëü/ë. Ïåðåâåäåíà â ÎÐÈÒ. Ãåìîäèíàìèêà çà âñå âðåìÿ íàáëþäåíèÿ áûëà ñòàáèëüíîé. Ðàçâèòèå ÎÏÍ áûëî ðàñöåíåíî, êàê íåôðîòîêñè÷åñêèé ýôôåêò êîíòðàñòà íà ôîíå óæå èìåþùåéñÿ äèàáåòè÷åñêîé íåôðîïàòèè.
 ê/î èíôóçèè 800 ìë, ôóðîñåìèä ñóììàðíî - 300 ìã, îòâåòà íåò.
 ÎÐÈÒ - ÖÂÄ 20 ñì âîä. ñò. Íàçíà÷åíî:
-ôóðîñåìèä 200 ìã ñòðóéíî
-ìàííèò 15% 100 ìë, äâàæäû
-äîôàìèí 4 ìêã õ êã/ìèí
-Íàòðèÿ ãèäðîêàðáîíàò 4% 150 ìë (ìåò. àöèäîç)
-òðåíòàë 4,0 ìë ÷åðåç èíôóçîìàò

Çà 6 ÷àñîâ íàáëþäåíèÿ - ìî÷è íå ïîëó÷åíî íè êàïëè. Äàëüíåéøóþ äðîáíóþ ñòèìóëÿöèþ ôóðîñåìèäîì è ìàííèòîì ïðåêðàòèë ïî ýòîé ïðè÷èíå. Æäàë, ÷òî óòðîì äîãîâîðèìñÿ îá ýêñòðàêîðïîðàëüíûõ ìåòîäàõ. Íî íå òóò òî áûëî. Íà ïëàíåðêå ïîäâåðãñÿ ðåçêîé êðèòèêå, ÷òî ÿ äîëæåí áûë ñòèìóëèðîâàòü äèóðåç ôóðîñåìèäîì äî 3 ãðàìì, è íàçíà÷èòü ïðåäíèçîëîí, êàê ìèíèìóì 300 ìã, ïëþñ ðåîïîëèãëþêèí (!) è ïðî÷àÿ èíôóçèîííàÿ òåðàïèÿ â êîë-âå 1500 ìë.
Âñå ìîè äîâîäû î ïîëíîé àíóðèè è áåññìûñëåííîñòè óøàòûâàòü ïî÷êè ïåòëåâûìè äèóðåòèêàìè áûëè íå óñëûøàíû. Ïðî ÖÂÄ òåðàïåâòû ïîíÿòèÿ íå èìåþò.

Õî÷ó óñëûøàòü âàøè ìíåíèÿ, êàê ïðàâèëüíî âåñòè òàêèõ ïàöèåíòîâ.

Êîììåíòàðèè ê ñîîáùåíèþ:
tourunov îäîáðèë(à): êñòàòè, õîðîøàÿ ðàáîòà êàðäèîëîãîâ è ñêîðîé ïîìîùè, ïîçäðàâëÿþ! òåïåðü, ãëàâíîå, ëå÷èòå ÊÈÍ (êîíòðàñò-èíäóöèðîâàííóþ íåôðîïàòèþ)
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 17.07.2011, 16:20
Àâàòàð äëÿ mountainbeaver
mountainbeaver mountainbeaver âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 16.07.2011
Ãîðîä: yekaterinburg
Ñîîáùåíèé: 29
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
mountainbeaver ýòîò ó÷àñòíèê èìååò õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò AMBU Ïîñìîòðåòü ñîîáùåíèå
 ê/î èíôóçèè 800 ìë, ôóðîñåìèä ñóììàðíî - 300 ìã, îòâåòà íåò.
 ÎÐÈÒ - ÖÂÄ 20 ñì âîä. ñò. Íàçíà÷åíî:
-ôóðîñåìèä 200 ìã ñòðóéíî
-ìàííèò 15% 100 ìë, äâàæäû
-äîôàìèí 4 ìêã õ êã/ìèí
-Íàòðèÿ ãèäðîêàðáîíàò 4% 150 ìë (ìåò. àöèäîç)
-òðåíòàë 4,0 ìë ÷åðåç èíôóçîìàò
-----------------------------------
Íà ïëàíåðêå ïîäâåðãñÿ ðåçêîé êðèòèêå, ÷òî ÿ äîëæåí áûë ñòèìóëèðîâàòü äèóðåç ôóðîñåìèäîì äî 3 ãðàìì, è íàçíà÷èòü ïðåäíèçîëîí, êàê ìèíèìóì 300 ìã, ïëþñ ðåîïîëèãëþêèí (!) è ïðî÷àÿ èíôóçèîííàÿ òåðàïèÿ â êîë-âå 1500 ìë.
à çà÷åì ìàííèò? îñìîëÿðíîñòü è òàê âûñîêàÿ
à òðåíòàë?
-----
ðåîïîëèãëþêèí, 3 ã ëàçèêñà - ýòî ÷òî-òî èç 80õ

Êîììåíòàðèè ê ñîîáùåíèþ:
îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 17.07.2011, 16:31
Àâàòàð äëÿ AMBU
AMBU AMBU âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 14.12.2008
Ãîðîä: Àëìàòû
Ñîîáùåíèé: 32
Ñêàçàë(à) ñïàñèáî: 10
AMBU ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Òðåíòàë - íàâÿçàëè êîëëåãè, äåæóðèâøèå ñî ìíîé. Ïîñ÷èòàë, ÷òî ïóñêàé, íå íàâðåäèò æå (?). Íà óòðî íåôðîëîãè ïðèøëè è òîæå åãî íàçíà÷èëè. ×òî ñàìîå èíòåðåñíîå, ïàöèåíòêà ñåé÷àñ ïîëó÷àåò òðåíòàë è ôóðîñåìèä (1000 ìã â ñóòêè) êàïåëüíî, è ìî÷à åñòü áîëåå 2 ëèòðîâ â ñóòêè. Ïðàâäà "øëàêè" íå ñíèæàþòñÿ. ß îáúÿñíþ ïîëèóðè÷åñêîé ñòàäèåé è ñòèìóëÿöèåé ïîñëåäíèõ íåôðîíîâ ñ ïîñëåäóþùåé èõ ãèáåëüþ. Ìíå ñòàâÿò â óêîð, ÷òî íàäî ìåíüøå óìíè÷àòü - ó íèõ åñòü ðåçóëüòàò, à ó ìåíÿ ìî÷è íîëü áûëî.
Ìàííèò - ìîÿ èíèöèàòèâà, ïðèçíàþ îøèáêó. Íå çíàë ÷òî åùå äåëàòü, ïîòîì ðåøèë, ÷òî áîëüíîé íóæäàåòñÿ â ìîåì óõîäå. Êóäà ïîäàëüøå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 17.07.2011, 18:56
Àâàòàð äëÿ FRSM
 FRSM  FRSM âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 12.06.2007
Ãîðîä: Airstrip One
Ñîîáùåíèé: 4,766
Ïîáëàãîäàðèëè 697 ðàç(à) çà 672 ñîîáùåíèé
FRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåFRSM ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
1. Áûëà ëè á-ÿ êàòåòåðèçèðîâàíà?

2. Ðàçîáðàëèñü ëè â òèïå íåäîñòàòî÷íîñòè:
- ïðåäïî÷å÷íàÿ;
- ïî÷å÷íàÿ;
- ïîñòïî÷å÷íàÿ


ò.å. áûëî ëè ïðîâåäåíî ÓÇÈ ñèñòåìû?
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 17.07.2011, 19:03
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,273
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,622 ðàç(à) çà 32,696 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
 ïðèíèöïå åñòü ðåêîìåíäàöèè ïî óìåíüøåíèþ ðèñêîâ íàðàñòàíèÿ ÕÏÍ ïðè ââåäåíèè êîíòðàñòîâ ëèöàì ñ äèàáåòè÷åñêîé íåôðîïàòèåé, íàïðÿæíî êàê-òî ñ áèêàðáîíàòàìè - ÷òî òàì áûëî â ÊÙÑ ?
__________________
Ã.À. Ìåëüíè÷åíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 17.07.2011, 21:12
Àâàòàð äëÿ DrDolgova
DrDolgova DrDolgova âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 24.02.2010
Ãîðîä: Êèåâ
Ñîîáùåíèé: 231
Ñêàçàë(à) ñïàñèáî: 13
Ïîáëàãîäàðèëè 33 ðàç(à) çà 28 ñîîáùåíèé
DrDolgova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrDolgova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrDolgova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrDolgova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Èñõîäÿ èç ïðåäîñòàâëåííûõ äàííûõ, áàáóøêà ïðèøëà ê Âàì óæå õîðîøî "ïîäãîòîâëåííîé", è åñëè ñ÷èòàòü, ÷òî âåñèò îíà 80 êã, òî èñõîäíûé êëèðåíñ êðåàòèíèíà ó íåå ñîñòàâëÿë âñåãî 30 ìë/ìèíóòó. Íå âäàâàÿñü â îáñóæäåíèå ðåêîìåíäàöèé òåðàïåâòè÷åñêîé ïëàíåðêè, ñêàæó, êàê ìû ñ òàêèìè ïîñòóïàåì. Êëþ÷åâîé ôðàçîé â èõ âåäåíèè ñ÷èòàåì ïîääåðæàíèå, íàñêîëüêî
ýòî âîçìîæíî, ïåðôóçèè ïî÷åê. Ýòî âêëþ÷àåò è ìàêñèìàëüíî âîçìîæíóþ ïåðèïðîöåäóðíóþ èíôóçèþ (ýòî, êîíå÷íî, íå ïðåäïîëàãàåò 1500 ìë íà ÖÂÄ 200, íî, åñëè "âëåçàåò", òî ñòàðàåìñÿ òàêîìó íàãîëîäàâøåìóñÿ áîëüíîìó íàêàïàòü äî 1 ëèòðà çà ñóòêè ïîñëå ñòåíòèðîâàíèÿ/êîðîíàðîãðàôèè). Åñëè æå íå âëåçàåò, òî - ðàñøèðåíûå è ðàííèå ïîêàçàíèÿ ê íàçíà÷åíèþ ñèìïàòîìèìåòèêîâ ñ öåëüþ ñîçäàíèÿ ïåðôóçèîííîãî äàâëåíèÿ, ïðè÷åì ôîðìàëüíûå 90-100 ñèñòîëè÷åñêîãî ÀÄ äëÿ ñòàðîãî äèàáåòèêà è ãèïåðòîíèêà ÷àñòî áûâàþò íåäîñòàòî÷íû, è ñîçäàåì 130 (îïÿòü æå, çàâèñèò îò ñòåïåíè ñåðäå÷íîé ñëàáîñòè è ò.ä.) Ñïåöèôè÷åñêèå ìåðû ïðîôèëàêòèêè ÊÈÍ (ò.å., ïîìèìî èíôóçèè - ÀÖÖ è ãèäðîêàðáîíàò) - íå ïðèìåíÿåì, ïîòîìó ÷òî çà ÀÖÖ íàäî êîãî-òî ñðî÷íî â àïòåêó ïîñûëàòü, à ãèäðîêàðáîíàò èñïîëüçóåì ïî äàíûì ÊÙÑ, à ñëåäîâàòü ðåêîìåíäàöèÿì èñïîëüçîâàòü åãî ïðîôèëàêòè÷åñêè - òîãäà íàäî ñëåäîâàòü èì â òî÷íîñòè, à ýòî ïðåäïîëàãàåò èíôóçèþ (ïîñòîÿííóþ) çà 1 ÷àñ äî è â òå÷ 6 ÷àñîâ ïîñëå âìåøàòåëüñòâà ïîðÿäêà 20 ìë íàøåãî 4% ãèäðîêàðáîíàòà íàòðèÿ â ÷àñ (1ìë/êã/÷àñ 1%) - âîçèòüñÿ íå õî÷åòñÿ.
ÍÎ â öåëîì, ðèñê âëåòåòü â ïîäîáíóþ ñèòóàöèþ ó íåå áûë î÷åíü âûñîê, îíà òðåáîâàëà ÷àñòîãî êîíòðîëÿ è äèóðåçà, è ÊÙÑ. Êîëè÷åñòâî ââåäåííîãî ôóðîñåìèäà íà ïðîãíîç íå âëèÿåò, à óñóãóáëÿåò ïîâðåæäåíèå ïî÷åê. 3ãðàììà - íîó êîììåíòñ.

Êîììåíòàðèè ê ñîîáùåíèþ:
Melnichenko îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 18.07.2011, 03:47
Àâàòàð äëÿ AMBU
AMBU AMBU âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 14.12.2008
Ãîðîä: Àëìàòû
Ñîîáùåíèé: 32
Ñêàçàë(à) ñïàñèáî: 10
AMBU ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò FRSM Ïîñìîòðåòü ñîîáùåíèå
1. Áûëà ëè á-ÿ êàòåòåðèçèðîâàíà?

2. Ðàçîáðàëèñü ëè â òèïå íåäîñòàòî÷íîñòè:
- ïðåäïî÷å÷íàÿ;
- ïî÷å÷íàÿ;
- ïîñòïî÷å÷íàÿ


ò.å. áûëî ëè ïðîâåäåíî ÓÇÈ ñèñòåìû?
1. Äà, ñðàçó ïðè ïîñòóïëåíèè â ÎÐÈÒ. Ïðè ïåðåâîäå â ê/î êàòåòåð óäàëåí. Ó÷èòûâàÿ æàëîáû íà çàäåðæêó ìî÷è, êàðäèîëîãè óñòàíîâèëè åãî âíîâü. Ïðè ïåðåâîäå â ÎÐÈÒ, êàòåòåð áûë çàìåíåí è ïðîâåðåíà åãî ôóíêöèîíàëüíîñòü. Ïîëó÷åíà îñòàòî÷íàÿ ìî÷à â êîë-âå 20 ìë.
2. Äà, ðàñöåíèëè êàê ðåíàëüíóþ ôîðìó ÎÏÍ. Íåñòàáèëüíîñòè ãåìîäèíàìèêè çàôèêñèðîâàíî íå áûëî ñ ìîìåíòà ïðèåçäà ñêîðîé.
ÓÇÈ áûëî ïðîâåäåíî óòðîì ïîñëå ïåðåâîäà. Íèêàêîãî îñòðîãî êðèìèíàëà. Ïðèçíàêè ÕÏÍ.

Öèòàòà:
Ñîîáùåíèå îò Melnichenko Ïîñìîòðåòü ñîîáùåíèå
 ïðèíèöïå åñòü ðåêîìåíäàöèè ïî óìåíüøåíèþ ðèñêîâ íàðàñòàíèÿ ÕÏÍ ïðè ââåäåíèè êîíòðàñòîâ ëèöàì ñ äèàáåòè÷åñêîé íåôðîïàòèåé, íàïðÿæíî êàê-òî ñ áèêàðáîíàòàìè - ÷òî òàì áûëî â ÊÙÑ ?
Ïðè ïîñòóïëåíèè-
ÊÙÑ:
pH 7.25
BE -8.5
Á/Õ: ãëèêåìèÿ - 11,2
Êàëèé - 5.3
Íàòðèé - 136

Êîëëåãè, ñïàñèáî çà îòâåòû. Õîòåëîñü áû óñëûøàòü åùå ìíåíèÿ îòíîñèòåëüíî ñòèìóëèðîâàíèÿ äèóðåçà ïåòëåâûìè äèóðåòèêàìè ïðè àíóðèè è ïðèìåíåíèè ãîðìîíîâ ñ öåëüþ "ñíÿòü îòåê â ïî÷êàõ".
Òàêèå ïàöèåíòû ðåäêè â êàðäèîöåíòðå, ïðîøó íå óäèâëÿòüñÿ, ÷òî ïîäîáíûå ìîìåíòû âûçûâàþò ó íàñ âîïðîñû.
Ñïàñèáî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 18.07.2011, 10:12
Àâàòàð äëÿ thorn
thorn thorn âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 10.04.2003
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 782
Ïîáëàãîäàðèëè 15 ðàç(à) çà 15 ñîîáùåíèé
thorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò AMBU Ïîñìîòðåòü ñîîáùåíèå
Êîëëåãè, ñïàñèáî çà îòâåòû. Õîòåëîñü áû óñëûøàòü åùå ìíåíèÿ îòíîñèòåëüíî ñòèìóëèðîâàíèÿ äèóðåçà ïåòëåâûìè äèóðåòèêàìè ïðè àíóðèè è ïðèìåíåíèè ãîðìîíîâ ñ öåëüþ "ñíÿòü îòåê â ïî÷êàõ".
Íå î÷åíü ïîíÿòíî, ïî÷åìó íå çàêîí÷èëè òðîìáîëèçèñ, à ïîøëè íà ×ÊÂ, äà åùå íà äâå àðòåðèè? Åñëè óæ ïî÷åìó-òî ðåøèëè äåëàòü ×Ê - âñå ÷òî íóæíî áûëî ïàöèåíòêå, òàê ýòî èíôóçèÿ ôèç. ðàñòâîðà 1 ìë/êã/÷.
Ïî äèóðåòèêàì ïðè ÎÏÍ:
Expert opinion of the Working Group for Nephrology, ESICM. Prevention of acute kidney injury and protection of renal function in the intensive care unit. 2010
Öèòàòà:
We recommend that loop diuretics are not used to prevent or ameliorate AKI (grade 1B).
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Öèòàòà:
Diuretics can be given to test renal responsiveness after adequate fluid loading, but should be discontinued if there is no or insufficient response to avoid side effects such as ototoxicity. Diuretics do not reduce mortality or morbidity nor improve renal outcome (210–213). However, if urine production is restored this will facilitate fluid management in patients who are critically ill, and this can be a reason for use of diuretics provided that the kidneys are still responsive.
Êîíêðåòíî äëÿ ÊÈÍ:
Öèòàòà:
Am J Kidney Dis. 2009 Oct;54(4):602-9. Epub 2009 Jun 17.
Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
Majumdar SR, Kjellstrand CM, Tymchak WJ, Hervas-Malo M, Taylor DA, Teo KK.
Source
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Abstract
BACKGROUND: Contrast-induced nephropathy is common in patients with coronary angiography. Mechanistically, forced euvolemic diuresis with mannitol and furosemide ought to prevent contrast-induced nephropathy. Our objectives are to: (1) undertake a randomized trial testing this hypothesis, and (2) conduct a meta-analysis of our findings with 2 earlier studies.
STUDY DESIGN: (1) Randomized allocation-concealed controlled trial with blinded ascertainment of outcomes, and (2) random-effects meta-analysis of 3 trials.
SETTING & PARTICIPANTS: Single-center study of consenting adults with serum creatinine level greater than 1.7 mg/dL undergoing coronary angiography; patients unable to tolerate fluid challenge or receiving dialysis were excluded. Two previous trials had randomly assigned 159 patients.
INTERVENTION: Forced euvolemic diuresis with saline, mannitol, and furosemide compared with saline hydration controls. All patients were pretreated with at least 500 mL of half-normal saline before angiography; during and 8 hours after, urine output was replaced milliliter per milliliter with half-normal saline.
OUTCOMES & MEASUREMENTS: The primary outcome was contrast-induced nephropathy within 48 hours of the procedure, defined as a 0.5-mg/dL absolute or 25% relative increase in creatinine level.
RESULTS: Overall, 92 patients were allocated to intervention (n = 46) or control (n = 46). Mean age was 64 +/- 14 (SD) years, 23% were women, 37% had diabetes, 47% used oral furosemide, mean creatinine level was 2.8 +/- 1.6 mg/dL, and most patients (72%) underwent diagnostic catheterization. Patients had a net positive fluid balance (389 +/- 958 mL for intervention versus 655 +/- 982 mL for controls; P = 0.2). Contrast-induced nephropathy occurred in 23 (50%) intervention patients versus 13 (28%) controls (relative risk, 1.77; 95% confidence interval, 1.03 to 3.05; P = 0.03; adjusted odds ratio, 3.73; P = 0.03). Within 48 hours, creatinine level had increased by 0.8 +/- 1.1 mg/dL with intervention versus 0.2 +/- 0.6 mg/dL for controls (P = 0.002). Overall, 11 (12%) patients died or required dialysis, with no difference according to allocation status (P = 0.5). Random-effects meta-analysis of published data (3 trials; 251 patients) suggests furosemide-based interventions lead to significant harm compared with hydration: pooled relative risk, 2.15; 95% confidence interval, 1.37 to 3.37; I(2) = 0%.
LIMITATIONS: Small single-center study that cannot determine whether harms were related to furosemide, mannitol, or a combination.
CONCLUSIONS: Forced euvolemic diuresis led to a significantly increased risk of contrast-induced nephropathy. This strategy should be abandoned, and our results suggest that oral furosemide therapy perhaps should be held before angiography.

Êîììåíòàðèè ê ñîîáùåíèþ:
tourunov îäîáðèë(à): ïî òàêòèêå - ñîãëàñåí
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 19.07.2011, 08:43
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,273
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,622 ðàç(à) çà 32,696 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íàäî ñêàçàòü ,÷òî äëÿ ìåíÿ ýòà òåìà( êîíòðàñò -èíäóöèðîâàííàÿ íåôðîïàòèÿ ) äîñòàòî÷íî áîëåçíåííà .
Ñåé÷àñ îáúÿñíþ , ïî÷åìó.
Äâà ãîäà íàçàä ìû îòêðûëè îòäåëåíèå èíòåðâåíöèîííîé êàðäèîëîãèè ( à ó íàñ åñòü åùå è îòäåëåíèå äèàáåòè÷åñêîé ñòîïû ) ñïåöèàëüíî äëÿ ëèö ñ äèàáåòîì .
Åñòü ó íàñ è îòäåëåíèå íåôðîïàòèè ñ ãðóïïîé ãåìîäèàëèçà . Ïîñòîÿííî âûõîäÿò ðàáîòû íà òåìó ïðîôèëàêòèêè ÊÈÍ è áîðüáû ñ íåé .
Íî âîò åñëè ðàçäåë -" êàê ñèå íàçâàòü è êòî âèíîâàò" ÿ îñâîèëà ïðåêðàñíî , ÿñíîñòè â ïîíèìàíèè õîðîøî äîêàçàííîé êîððåêöèè óæå âîçíèêøåé ñèòóàöèè ( ÷òîá íà ðàç - äâà -òðè è âñå ïîíÿòíî ) ó ìåíÿ êàê íå áûëî , òàê è íåò
__________________
Ã.À. Ìåëüíè÷åíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 19.07.2011, 08:48
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,273
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,622 ðàç(à) çà 32,696 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïîýòîìó äëÿ ïðîäîëæåíèÿ ýòîé òåìû ÿ ðåøèëà âçÿòü ìîíîãðàôèþ Ñàõàðíûé äèàáåò è õðîíè÷åñêàÿ áîëåçíü ïî÷åê ( ÌÈÀ ) Øåñòêîâîé è Äåäîâà îò 2009 è ïîïðîáîâàòü ïðîñòî èçëîæèòü ãëàâó îá ýòîé ñàìîé êëÿòîé ÊÈÍ - è áóäó æäàòü êîììåíòàðèåâ è âïðàâäó âñå ñèå äåëàâøèõ ...

C äåôèíèöèåé âñå ïîíÿòíî - "ÊÈÍ äèàãíñòèðóþò ïðè ïîâûøåíèè óðîâíÿ êðåàòèíèíà íà 44 ìêìîëü \ ë ( èëè íà 25 % îò áàçàëüíîãî óðîâíÿ ) â òå÷åíèå 48 ÷ñàñîâ ïîñëå ââåäåíèÿ êîíòðàñòà â îòñóòñòâèè àëüòåðíàòèâíûõ ïðè÷èí"

Ïîíÿòíî ñî ñòðàòèôèêàöèåé ðèñêà ãðÿäóùåãî áåäñòâèÿ :
ÑÄ ñàì ïî ñåáå è âîçðàñò ñòàðøå 75 ëåò äàþò ïî 3 áàëëà , èòîãî ýòèõ äâóõ ââîäíûõ äîñòàòî÷íî , ÷òîáû ðèñê ñòàë õîòÿ áû óìåðåííûì.
Îñòàëüíîå ïåðå÷èñëÿòü íå áóäó - çíàåòå áåç ìåíÿ .

Ñàìûé ëþáîïûòíûé ðàçäåë - ÏÐÎÔÈËÀÊÒÈÊÀ
Íà÷àëî îïòèìèñòè÷íî :
Äëÿ ïðîôèëàêòèêè ïðåäëîæåíî ìíîãî ñðåäñòâ :
ïåðèïðîöåäóðíàÿ ãèäðàòàöèÿ
íàòðèÿ áèêàðáîíàò
N - àöåòèëöèñòåèí
òåîôèëëèí
äèóðåòèêè
áëîêàòîðû êàëüöèåâûõ êàíàëîâ
äîôàìèí
àíòàãîíèñòû ýíäîòåëèíà
ïðåäñåðäíûé íàòðèóðåòè÷åñêèé ïåïòèä
ôåíîëäîïàì
ÈÀÏÔ ( ? )
ïðîñòàãëàíäèí Å1
àñêîðáèíîâàÿ êèñëîòà
ÃÄ ïîñëå êîíòðàñòà
Ãåìîôèëüòðàöèÿ â òå÷åíèå è ïîñëå êîíòðàñòà

Âðîäå êàê ìíîãî ( ïîíåâîëå âñïîìíèøü ×åõîâà - "åñëè ïðîòèâ êàêîé -òî áîëåçíè ìíîãî ëåêàðñòâ , áîëåçíü íåèçëå÷èìà" )
Äàëåå ñëåäóåò áîäðÿùåå :îäíàêî â õîäå ïðîñïåêòèâíûõ ðàíäîìèçèðîâàííûõ äâîéíûõ ñëåïûõ .... ÍÅ ÏÎÄÒÂÅÐÄÈËÀÑÜ ýôôåêòèâíîñòü
äèóðåòèêîâ
ìàííèòîëà
äîôàìèíà
ïðåäñåðäíîãî íàòðèóðåòè÷åñêîãî
àíòàãîíèñòîâ ðåöåïòîðîâ ýíäîòåëèíà
ôåíîëäîïàìà
áëîêàòîðîâ êàëüöèåâûõ
ïðîñòàãëàíäèíà Å1


È õîòÿ ñïèñîê êðàéíå ñîêðàòèëñÿ , îñòàâàëàñü åùå íàäåæäà , ÷òî õîòü îñòàòêè íåïëîõè ( òîò æå àöåòèëöèñòåèí )
Íî íå òóò -òî áûëî
( ïðîäîëæåíèå ñëåäóåò )
__________________
Ã.À. Ìåëüíè÷åíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 19.07.2011, 11:13
Àâàòàð äëÿ DrDolgova
DrDolgova DrDolgova âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 24.02.2010
Ãîðîä: Êèåâ
Ñîîáùåíèé: 231
Ñêàçàë(à) ñïàñèáî: 13
Ïîáëàãîäàðèëè 33 ðàç(à) çà 28 ñîîáùåíèé
DrDolgova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrDolgova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrDolgova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrDolgova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Òîïèêñòàðòåðó: êîðòèêîñòåðîèäû èìåþò ïðîòèâîîòå÷íîå äåéñòâèå òîëüêî â îòíîøåíèè ïåðèôîêàëüíîãî îòåêà âîêðóã îïóõîëåé ãîëîâíîãî ìîçãà. È âñå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #12  
Ñòàðûé 19.07.2011, 12:09
Àâàòàð äëÿ AMBU
AMBU AMBU âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 14.12.2008
Ãîðîä: Àëìàòû
Ñîîáùåíèé: 32
Ñêàçàë(à) ñïàñèáî: 10
AMBU ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò thorn Ïîñìîòðåòü ñîîáùåíèå
Íå î÷åíü ïîíÿòíî, ïî÷åìó íå çàêîí÷èëè òðîìáîëèçèñ, à ïîøëè íà ×ÊÂ, äà åùå íà äâå àðòåðèè? Åñëè óæ ïî÷åìó-òî ðåøèëè äåëàòü ×Ê - âñå ÷òî íóæíî áûëî ïàöèåíòêå, òàê ýòî èíôóçèÿ ôèç. ðàñòâîðà 1 ìë/êã/÷.
Òðîìáîëèçèñ áûë çàêîí÷åí íà äîãîñïèòàëüíîì ýòàïå. Ñêîðàÿ ðåäêî ïðèìåíÿåò Àêòèëèçå ñâûøå 50 ìã, åñëè âîçðàñò ïàöèåíòà ñòàðøå 70 ëåò. Òàì áûëî òðåõ ñîñóäèñòîå ïîðàæåíèå, èíòåðâåíöèîíèñò Πîñòàâèë íà áóäóùåå, ïîòîìó ÷òî êîíòðàñòà óøëî íà òîò ìîìåíò óæå ïðèëè÷íî. Ïàöèåíòêà îò ÀÊØ îòêàçàëàñü áû â ëþáîì ñëó÷àå, îíà è íà êîðîíàðîãðàôèþ ñ òðóäîì ñîãëàñèëàñü.
Öèòàòà:
Ñîîáùåíèå îò Melnichenko Ïîñìîòðåòü ñîîáùåíèå
Íàäî ñêàçàòü ,÷òî äëÿ ìåíÿ ýòà òåìà( êîíòðàñò -èíäóöèðîâàííàÿ íåôðîïàòèÿ ) äîñòàòî÷íî áîëåçíåííà .
Ñåé÷àñ îáúÿñíþ , ïî÷åìó.
Äâà ãîäà íàçàä ìû îòêðûëè îòäåëåíèå èíòåðâåíöèîííîé êàðäèîëîãèè ( à ó íàñ åñòü åùå è îòäåëåíèå äèàáåòè÷åñêîé ñòîïû ) ñïåöèàëüíî äëÿ ëèö ñ äèàáåòîì .
Åñòü ó íàñ è îòäåëåíèå íåôðîïàòèè ñ ãðóïïîé ãåìîäèàëèçà . Ïîñòîÿííî âûõîäÿò ðàáîòû íà òåìó ïðîôèëàêòèêè ÊÈÍ è áîðüáû ñ íåé .
Ýòî ãäå òàêîå?
Öèòàòà:
Ñîîáùåíèå îò DrDolgova Ïîñìîòðåòü ñîîáùåíèå
Òîïèêñòàðòåðó: êîðòèêîñòåðîèäû èìåþò ïðîòèâîîòå÷íîå äåéñòâèå òîëüêî â îòíîøåíèè ïåðèôîêàëüíîãî îòåêà âîêðóã îïóõîëåé ãîëîâíîãî ìîçãà. È âñå.
Âîò èìåííî, è áîëåå òîãî - ñàìè ïî ñåáå îáëàäàþò íåôðîòîêñè÷åñêèì ýôôåêòîì.

Êîììåíòàðèè ê ñîîáùåíèþ:
tourunov îäîáðèë(à): âîò çäåñü http://www.endocrincentr.ru/
Îòâåòèòü ñ öèòèðîâàíèåì
  #13  
Ñòàðûé 19.07.2011, 12:47
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,273
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,622 ðàç(à) çà 32,696 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ýòî â ÝÍÖ ,. ( îòäåëåíèÿ Ãàëñòÿíà , Øàìõàëîâîé è Êàëàøíèêîâà )
Íó è äàëüøå î òîé ãðóïïå , êàêîâàÿ îñòàëàñü èç ñèëüíî ïîðåäåâøåãî ñïèñêà ..
K Spragis et al ïðîñïåêòèâíîå ðàíäîìèçèðîâàííîå - 7 ãðàìì àñêîðáèíêè ñòàòèñòè÷åñêè çíà÷èìî ñíèæàþò âåðîÿòíîñòü ÊÈÍ .
Íî !! âåëåíî ïåðåïðîâåðèòü è â ðåêîìåíäàöèè ïîêà íå âîøëî ( äàííûå íà 2009 ãîä - íå ïðåïðîâåðÿëà äàëüøå )

Êîììåíòàðèè ê ñîîáùåíèþ:
tourunov îäîáðèë(à): â êàðäèîëîãè÷åñêèå ðåêîìåíäàöèè òî÷íî íå âîøëî
__________________
Ã.À. Ìåëüíè÷åíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #14  
Ñòàðûé 19.07.2011, 13:09
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,273
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,622 ðàç(à) çà 32,696 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Äàëåå èäåò ñëåäóþùàÿ ìûñëü : ïîñîêëüêó ãèïåðãëèêåìèÿ ïî ñóòè åñòü äåãèäðàòàöèÿ , à ïåðèïðîöåäóðíàÿ ãèäðàòàöèÿ - ñòàíäàðòíàÿ ðåêîìåíäàöèÿ , òî ìàêñèìàëüíî âîçìîæíàÿ äëÿ äàííîãî ÷åëîâåêà áåç ðèñêà êîìïåíñàöèÿ ïî ñóòè óæå ÷àñòü ïåðèïðîöåäóðíîé ãèäðàòàöèè .
Ýòî íà àâòîìàòå ó ëþáîãî ýíäîêðèíîëîãà , äî ýòîãî ìû ñïîñîáíû äîäóìàòüñÿ.
Ñàìà æå âíóòèðèâåííàÿ ïåðèïðîöåäóðíàÿ ãèäðàòàöèÿ : ïî ðåæèìó
1.Âíóòðèâåííî ôèç ð-ð ñî ñêîðîñòüþ 1ìë\êã â òå÷åíèå 24 ÷àñîâ è íåîãðàíè÷åííûé ïåðîðàëüíûé ïðèåì, íà÷èíàÿ çà 12 ÷àñîâ äî ïðîöåäóðû, ïîêàçàëè ïðåèìóùåñòâà ïî ñðàâíåíèþ ñ ïåðîðàëüíîé ãèäðàòàöèåé,
Êòî õîðîøî ïîíÿë ñêîëüêî è ÷åãî , ìîæåò ïîäíÿòü ðóêè - ìíå ïðèäåòñÿ èäòè çà ñïðàâêàìè ...
Âðîäå êàê ñìóòíî òàê :
ÑÊÔ ñíèçèëàñü áîëüøå ( -34. 6 è - 18. 3 ) , åñëè äàëè òîëüêî 300 ìë ôèç ð-ðà â òå÷åíèå êîíòðàñòíîé ïðîöåäóðû è íåîãðàíè÷åííîãî ïèòüÿ ïî ñðàâíåíèþ ñ òåìè , êîìó êàïàëè 12 ÷àñ äî è 12 ÷àñ ïîñëå ïðîöåäóðû ( ó àâòîðîâ íåò â ýò îì ìåñòå ññûëêè )
Ýòî ïðîòèâîðå÷èò PREPARED ( Preparation for angiography in renal disfunction) ãäå àìáóëàòîðíî âûïèòûé ëèòð çà 10 ÷àñîâ â ñî÷åòàíèè ñ â\â 300 ìë \÷àñ ÃÈÏÎÒÎÍÈ×ÅÑÊÎÃÎ ( ! ) ð-ðà çà 6 ÷àñ äî ÊÀà áûëè ðàâíî ýôôåêòèâíû ñ â\â 75 ìë\÷àñ çà 12 ÷àñ äî ïðîöåäóðû â òå÷åíèå 24 ÷àñîâ

Íà ýòîì ìåñòå ìîè ìîçãè óæå êèïÿò - à âïåðåäè åùå 4 èññëåäîâàíèÿ ....
__________________
Ã.À. Ìåëüíè÷åíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #15  
Ñòàðûé 19.07.2011, 14:11
Àâàòàð äëÿ thorn
thorn thorn âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 10.04.2003
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 782
Ïîáëàãîäàðèëè 15 ðàç(à) çà 15 ñîîáùåíèé
thorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåthorn ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò AMBU Ïîñìîòðåòü ñîîáùåíèå
Òðîìáîëèçèñ áûë çàêîí÷åí íà äîãîñïèòàëüíîì ýòàïå. Ñêîðàÿ ðåäêî ïðèìåíÿåò Àêòèëèçå ñâûøå 50 ìã, åñëè âîçðàñò ïàöèåíòà ñòàðøå 70 ëåò. Òàì áûëî òðåõ ñîñóäèñòîå ïîðàæåíèå, èíòåðâåíöèîíèñò Πîñòàâèë íà áóäóùåå, ïîòîìó ÷òî êîíòðàñòà óøëî íà òîò ìîìåíò óæå ïðèëè÷íî. Ïàöèåíòêà îò ÀÊØ îòêàçàëàñü áû â ëþáîì ñëó÷àå, îíà è íà êîðîíàðîãðàôèþ ñ òðóäîì ñîãëàñèëàñü.
Ò.å. ýòî áûëî íå "ñïàñèòåëüíîå" ×ÊÂ?  êàêèå ñðîêè åå âçÿëè? Òîãäà íåïîíÿòíî, ïî÷åìó íå ãîòîâèëè... È ïî÷åìó äâå àðòåðèè, åñëè ïîíÿòíî ÷òî êîíòðàñòà íåìàëî óéäåò?
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 12:51.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.